Pablo Corral MD ✓

@drpablocorral · -38.015717,-57.537636 · joined 24 Sep 2009

Past President Argentine Lipid Society. Internal Medicine Doctor. School of Medicine Professor. Lipidologist. Atherosclerosis. CV Prevention.

13 714Followers

2 066Following

17 243Posts total

274.2KViews on collected posts

Against accounts of the same size

7 posts from the last 90 days, next to the 10K–100K follower range. shown widely, but few of those viewers react.

Median views28 993this account3 808median for 10K–100K

Reach, %211.41%this account12.23%median for 10K–100K

Engagement, %0.68%this account1.37%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	28 993	3 808	7.61×
Reach (views ÷ followers)	2.1× audience	12.23%	17.3×
Engagement rate	0.68%	1.37%	0.50×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

104.7K29 Aug

29K30 Aug

10.7K

84.3K31 Aug

36.1K

2.7K1 Sep

6.7K2 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.70%29 Aug

0.42%30 Aug

0.68%

0.51%31 Aug

0.46%

2.06%1 Sep

2.84%2 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.37%.

What the audience does

Likes59.7%1 317 in total

Reposts14.6%321 in total

Replies4.4%98 in total

Quotes1.5%32 in total

Bookmarks19.9%438 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

ESC Congress 2026 🇩🇪 | My Top 20 Lipidology Highlights After an intense few days in Munich — including the opportunity to present our own work — here is my personal selection of the 20 lipid studies and concepts that caught my attention at ESC 2026. 1- VESALIUS-CV | Evolocumab 6.7K views · 145 likes · 36 reposts · 6 replies 02 Sep 2026 Wrapping up ESC Congress 2026 in Munich 🇩🇪 Another intense and rewarding ESC Congress comes to an end. A few days filled with science, discussion, collaboration, and many opportunities to exchange ideas with colleagues from around the world. Some personal highlights: 🔬 https:/ 2.7K views · 48 likes · 6 reposts · 1 replies 01 Sep 2026 ☝️VESALIUS-CV adds an important new piece to the evidence supporting intensive LDL-C lowering and even more important one regarding when we should intervene. 👉In this prespecified mortality analysis, 12,257 high-risk patients without prior MI or stroke were randomized to https:/ 36.1K views · 118 likes · 31 reposts · 11 replies 31 Aug 2026 ☝️If we continue to consider LDLc levels of 100–120 mg/dL “acceptable,” we should not be surprised to find atherosclerosis already present in young adults 👉LDLc levels above approximately 40–50 mg/dL are supraphysiological. Lifelong exposure to higher LDLc levels drives 84.3K views · 333 likes · 57 reposts · 35 replies 31 Aug 2026 You’re asking why dementia wasn’t reduced I’m asking why a 43% reduction in MI is being treated as if it were clinically irrelevant One of us seems more concerned with the results of the trial than with the results the trial didn’t show Absence of evidence is not evidence of 10.7K views · 65 likes · 1 reposts · 7 replies 30 Aug 2026 Do you want this drug, you might get less heart attacks, but you wont reliably live longer even after 6 years of taking it, and you wont have any less disability or less dementia. I am surprised a lipidologist like you cannot ask a simple question why it DIDNT reduce dementia? 29K views · 96 likes · 9 reposts · 16 replies 30 Aug 2026 ☝️Atherosclerosis starts earlier than we think 👉New data from the REACT study, published in NEJM, provide a striking picture of silent atherosclerosis across adult life: 1️⃣ 16,808 adults, aged 18–70 years, without known ASCVD. 2️⃣ Multimodal imaging included 3D carotid and htt 104.7K views · 512 likes · 181 reposts · 22 replies 29 Aug 2026